Advertisement

Topics

Teva teeters on junk rating as sell off in bonds accelerates7 minutes ago

14:49 EDT 4 Aug 2017 | Topix

Teva Pharmaceutical Industries Ltd. is teetering on the edge of a junk rating amid its biggest bond sell-off on record. Moody's Investors Service downgraded the drugmaker's debt to one step above junk on Thursday and warned that the company's ratings may be pressured lower over the next 12 to 18 months.

Original Article: Teva teeters on junk rating as sell off in bonds accelerates7 minutes ago

NEXT ARTICLE

More From BioPortfolio on "Teva teeters on junk rating as sell off in bonds accelerates7 minutes ago"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...